Published on : Jan 02, 2018
ALBANY, New York, Jan 02, 2018: The global tissue processing systems market has been predicted in a report added by ResearchMoz.us to gain growth on the back of increasing geriatric population, growing count of lifestyle disorders, technological developments, and rising occurrence of cancer. Titled “Tissue Processing Systems Market: Global Industry Analysis (2012-2016) and Forecast (2017-2025),” the report has foreseen a mounting adoption of tissue processing systems to take shape in the coming years. The market has been prognosticated to expand at a 5.7% CAGR to reach a valuation of close to US$0.4 bn by the completion of 2025. In 2017, the market had achieved a valuation of around US$0.2 bn.
As per the market taxonomy presented in the report, there are three segments that have been listed under the segmentation by product, viz. rapid high volume tissue processors, medium volume tissue processors, and small volume tissue processors. In terms of modality, the market has been segmented into bench-top tissue processing unit and standalone tissue processing unit. By end user, diagnostic laboratories and hospitals are the two segments that have been focused upon. On the basis of technology, the market has been classified into vacuum tissue processors and microwave tissue processors. Regionally, there are five geographies that have been closely studied, i.e. the Middle East and Africa (MEA), Asia Pacific (APAC), Europe, Latin America, and North America.
According to the report, small volume tissue processors could carry forward their dominance in the world tissue processing systems market all through the course of the forecast tenure. The segment has been foreseen to be valued at a US$0.1 bn by the final forecast year. Industry players may also want to focus on standalone tissue processing unit as it has been forecast to attain a larger share in the coming years while growing at a 6.6% CAGR. Expected to obtain a revenue of US$0.3 bn by 2025, vacuum tissue processors could take a leading position in the market under their segmentation category. Another segment, i.e. diagnostic laboratories has been foretold to be ranked higher as it reaches an expected revenue of US$0.2 bn by the concluding forecast year.
Get SAMPLE REPORT PDF: https://www.researchmoz.us/enquiry.php?type=S&repid=1396724
There could be high growth prospects taking birth in the international tissue processing systems market due to rising healthcare expenditure for offering advanced and affordable solutions. However, the market has been projected to be restrained by certain factors such as the rising adoption of refurbished tissue processing systems and high expense of automated systems. Nonetheless, there could be improvements in market growth owing to greater access to advanced tissue processors, increasing adoption in laboratories to improve efficiency, swelling focus on underdeveloped and developing markets, dearth of pathologists, and the consolidation of pathology laboratory tools with a single vendor.
The disproportionate rise of geriatric population and aggressive changes in healthcare reforms have been envisioned to be among the primary factors creating rewarding prospects in the MEA and APAC. This could lead to a rapid increase in the number of patients requiring diagnosis and screening to treat several chronic diseases. Emerging regions have been prophesied to be crucial markets for medical devices vendors. Moreover, governments in these regions have been largely focusing upon the improvement of healthcare infrastructure and spending.
The worldwide tissue processing systems market includes key players such as Milestone Srl, Slee Medical GmbH, Sakura Finetek Europe B.V., Thermo Fisher Scientific Inc., and Leica Biosystems Nussloch GmbH.
To order report Call USA – Canada Toll Free: 866-997-4948 or send an email on firstname.lastname@example.org